It is noted that compounds that promote Shh, Wnt, and Bmp signaling pathways have the potential to become therapeutic agents for alopecia and skin-related disorders derived from VDR deficiency. The gene discussed is VDR; the disease is hyperinsulinemic hypoglycemia, familial, 4.